IDiyas

For the Inventor, By the Inventor

Taichung, Taiwan

Chang-Hai Tsai

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal11 out of 99 
 
China Medical University
 patents

Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):
1. 12226437 - Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell (2025-02-18),
2. 11760980 - Induced pluripotent stem cells (IPSCS) and applications thereof (2023-09-19),
3. 11529373 - Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage (2022-12-20),
4. 11458171 - Engineering stem cells for cancer therapy (2022-10-04),
5. 11110129 - Method for treating multiple sclerosis (2021-09-07),
6. 10988733 - Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue (2021-04-27),
7. 10787413 - Derivatives of curcuminoids and use thereof as an anticancer agent (2020-09-29),
8. 10736964 - Immunomagnetic nanocapsule and kit for treating cancer (2020-08-11),
9. 10696945 - Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells (2020-06-30),
10. 10660918 - Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell (2020-05-26),
11. 10035791 - Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof (2018-07-31),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…